Ideas

win score
73

ELECON 15dQ8FRESH added 30 Oct 16:20 · valid to 2026-11-14 · since added

Catalyst · RESULTS: Q4 FY27 order book conversion into revenue (Jan 2027 results); FY28 guidance on margin and growth (Apr 2027 results) (2027-01-20)

Elecon Engineering: gear/material handling equipment, ROCE 20.9%, ROE 16.4%. Q2 FY27 sales ₹639 Cr (+10.6% YoY, +22.6% QoQ), OPM 23% (+200 bps QoQ), NP ₹96 Cr (+26% QoQ). Order book ₹1,640 Cr (+33% YoY). Margin expansion and order intake momentum intact despite TTM profit -31% (distorted by Mar 2026 tax anomaly: 85% rate). Desk logged 15d idea Oct 29: entry 430-445, stop 410, target 480-510 (conf 0.68).

Why now: Current 419.75 is below desk entry band (430-445) after -4% retrace from 437.5. Order intake +8% YoY to ₹750 Cr and margin expansion (+100 bps YoY, +200 bps QoQ) support thesis. Wait for pullback to e

Entry zone 430.0–445.0 · stop 410.0 · target 480.0–510.0 · now None

Wrong if: Order book conversion delay, OPM falls <10% in Q3, or capital goods cycle slowdown evident in order intake <₹600 Cr/quarter

win score
73

LOTUSDEV 15dQ8PARTLY_PRICED added 27 Oct 16:20 · valid to 2026-11-11 · since added

Catalyst · CAPACITY: Project launches (redevelopment, GIFT City, luxury) through Mar 2027; Q3 results (Jan 2027) will confirm pre-sales trajectory and margin sustainability. (2027-01-15)

Mumbai luxury/redevelopment developer. Q2 FY27: sales ₹269 Cr (+53% YoY), OPM 40% (+11 pts YoY), NP ₹89 Cr (+91% YoY). H1 pre-sales ₹879 Cr (+176% YoY). FY27 guidance ₹1,800-2,000 Cr. 22-project pipeline, GDV ₹17.5-18k Cr. Debt-free. Motilal Oswal BUY (16-Oct). Capital Group bought ~2% stake (22-Oct).

Why now: Stock near 52-week high (₹248.4), up 67.7% in 6m, but still 28.4% below IPO-era valuations. FY27 guidance de-risked by H1 execution (₹879 Cr pre-sales). Institutional buying (Capital Group) signals co

Entry zone 228.0–238.0 · stop 215.0 · target 255.0–270.0 · now None

Wrong if: Working capital days >550, debtors >180 days, or Q3 pre-sales <₹400 Cr (run-rate miss). Promoter stake dilution >1% in next quarter signals capital stress.

win score
71

HYUNDAI 15dQ6PARTLY_PRICED added 29 Oct 16:19 · valid to 2026-11-13 · since added

Catalyst · ORDER: Bayon launch ramp (Oct 2026); Q3 results (Jan 2027) to confirm volume/margin trajectory (2027-01-20)

Auto OEM. Q2 sales ₹20,696 Cr (+18.5% YoY), NP ₹1,196 Cr (+307 Cr QoQ). Parent $15.5B capex plan through 2032. Bayon SUV launch at ₹9.99L (entry segment, high volume). ROCE 38.4%, ROE 29.9%, debt-free. Brokerages see 31% upside (Nomura Buy, CLSA margin recovery).

Why now: Q2 beat announced Oct 28; parent capex plan Oct 14; Bayon launch Oct 27. FII exit (6.7%→3.2%) may be exhausted; DII accumulation (7.1%→11.9%) signals institutional support. Stock -17.7% off 52w high.

Entry zone 1900.0–1940.0 · stop 1820.0 · target 2050.0–2150.0 · now None

Wrong if: OPM falls below 9% in Q3 or Bayon volumes <10k units/month by Feb 2027

win score
70

CGPOWER 15dQ8PARTLY_PRICED added 29 Oct 16:19 · valid to 2026-11-13 · since added -3.1%

Catalyst · ORDER: Kavach 4.0 order execution ramp; Q3 results (Jan 2027) to confirm 30% YoY growth sustains (2027-01-25)

Power systems/industrial equipment. Q2 sales ₹3,802 Cr (+30% YoY), NP ₹409 Cr (+44% YoY), OPM 14%. RDSO approval for ₹433 Cr Kavach 4.0 order (Oct 26). ₹3,000 Cr QIP deployed. ROCE 26.7%, ROE 20.5%, debt-free. Motilal Oswal target ₹1,140 (+37%).

Why now: RDSO approval Oct 26 (3 days old); Q2 results Oct 23 showed 30% YoY sales, 44% YoY profit. Aerospace +72% YoY. Stock ₹829.8 is -15.4% off 52w high; RS 57.3% (neutral but improving). Working capital 69

Entry zone 820.0–845.0 · stop 785.0 · target 920.0–980.0 · now 804.0

Wrong if: Working capital days >80 or OPM <12% in Q3; Kavach order execution delays beyond Mar 2027

win score
70

STYLAMIND 15dQ8FRESH added 27 Oct 16:20 · valid to 2026-11-11 · since added

Catalyst · CAPACITY: Q2 FY27 results (28-Oct, tomorrow); capacity ramp commentary on Manak Tabra-2. Analyst consensus EPS ₹27.60 vs ₹22.17 YoY (+24%). (2026-10-28)

Decorative laminates manufacturer. Q1 FY27: sales ₹326 Cr (+15.2% YoY, +15.2% QoQ), OPM 31%, NP ₹48 Cr (+26% QoQ). Manak Tabra-2 plant (₹300 Cr capex, 5.25 MTPA capacity) commenced commercial production 22-Sep-2026. ROCE 26.6%, ROE 19.9%. Debt-free.

Why now: New plant live since 22-Sep; Q2 will show early ramp-up impact. Stock off 52-week high by 22.8%; pullback from -6.1% (3m) to +43.4% (6m) suggests consolidation. 15-day window captures results + early

Entry zone 3150.0–3220.0 · stop 2980.0 · target 3350.0–3500.0 · now None

Wrong if: Q2 sales <₹320 Cr, OPM <29%, or Manak Tabra-2 ramp-up delays. Capex overrun or cost inflation commentary. Export demand weakness (Europe/SE Asia).

win score
68

ATHERENERG 15dQ6FRESH added 26 Oct 16:20 · valid to 2026-11-10 · since added

Catalyst · CAPACITY: ₹122 Cr capacity expansion (Board-approved 26-Oct); Hosur ramp & Factory 3.0 commissioning progress in Q3 FY27 (2027-01-20)

EV 2-wheeler: Q2 FY27 sales ₹1,217 Cr (+89% YoY), operating loss narrowed to ₹33 Cr (OPM -2.7%) from ₹134 Cr (OPM -21%) Jun'25. Net profit ₹1.26 Cr Q2 vs loss ₹154 Cr YoY. Board approved ₹122 Cr capacity expansion (Hosur 495k, Factory 3.0 650k units). EBITDA margin 4.9%. IRDAI insurance license granted 15-Oct (new revenue stream).

Why now: Capacity expansion announced today (26-Oct); insurance license (15-Oct) adds revenue stream. Path to sustained profitability visible (EBITDA margin 4.9%, operating loss narrowing). 15d window captures

Entry zone 1540.0–1580.0 · stop 1450.0 · target 1680.0–1740.0 · now None

Wrong if: Capex execution delays or cost overruns; EV subsidy policy changes reduce demand; competitive price wars compress margins below 3% EBITDA.

win score
67

SHAILY 7dQ8FRESH added 27 Oct 16:20 · valid to 2026-11-03 · since added

Catalyst · RESULTS: Board meeting 29-Oct (2 days) to approve Q2 FY27 results; earnings call 30-Oct 4 PM. Management commentary on OEM demand, pricing, capex, FY27 guidance. (2026-10-29)

Precision injection-moulded plastics for OEMs. Q1 FY27: sales ₹281 Cr (+13.8% YoY), OPM 30% (+2 pts QoQ, +2 pts YoY), NP ₹48 Cr (+17.1% YoY). TTM sales +20%, profit +51%. ROCE 29.3%, ROE 26.9%. Debt-free. FII holding 19.4% (up from 7% in Dec 2023).

Why now: Q1 showed margin expansion and operating leverage. Stock split 1:5 approved 19-Oct (liquidity boost). 7-day window captures result release and call. Valuation stretched (P/E 80.2x) but quality and mom

Entry zone 3050.0–3100.0 · stop 2900.0 · target 3200.0–3350.0 · now None

Wrong if: Q2 sales <₹270 Cr, OPM <28%, or guidance cut. OEM order delays or capex deferral commentary. Promoter stake dilution >1%.

win score
65

POLYCAB 30dQ8FRESH added 19 Oct 16:19 · valid to 2026-11-18 · since added

Catalyst · APPROVAL: NCLAT hearing preponed (16-Oct filing): Asier Metals insolvency appeal verdict—dismissal removes legal risk (date not fixed)

Q2 FY27: sales ₹9,899 Cr (+52.4% YoY), NP ₹990 Cr (+43%). OPM stable 14%. NCLAT hearing preponed (16-Oct filing); outcome in next 2-4 weeks is binary catalyst. If insolvency dismissed, F&O exclusion reversed, risk premium removed. ROCE 33.2%, ROE 23%, debt-free. Quality 8/10.

Why now: NCLAT verdict expected in next 2-4 weeks. If insolvency dismissed, stock likely rebounds sharply (F&O exclusion reversed, risk premium removed). Q2 results strong (86% analyst buy), but legal overhang

Entry zone 7900.0–8100.0 · stop 7500.0 · target 8600.0–8900.0 · now None

Wrong if: NCLAT admits insolvency petition; CIRP process drags; F&O exclusion Dec 30 triggers forced selling; promoter stake falls below 55%.

win score
64

MASTEK 15dQ6FRESH added 21 Oct 16:19 · valid to 2026-11-05 · since added

Catalyst · RESULTS: Board meets 23-Oct for Q2 FY27 results (Sep-26 qtr). Earnings call to clarify Staffordshire deal value, Innovaccer scope, margin trajectory (OPM stuck 15-17% for 4 qtrs). If Q2 sales >₹1,000 Cr and OP (2026-10-23)

Q2 FY27 (Jun-26): sales ₹985 Cr (+7.7% YoY), NP ₹106 Cr flat QoQ, OPM 15%. Staffordshire County Council Oracle Cloud win (8-Oct), ISG Partnership Award (12-Oct), Innovaccer healthcare partnership (19-Oct). ROCE 17.7%, ROE 15.3%. Median 10y sales growth 18.3% vs TTM 6% shows deceleration.

Why now: Results 2 days away. Valuation fair (P/E 13.1 vs universe 25). Recent wins lack disclosed contract values; revenue timing uncertain. Watch for order book disclosure and margin inflection guidance.

Entry zone 1820.0–1860.0 · stop 1750.0 · target 1980.0–2060.0 · now None

Wrong if: Q2 sales <₹950 Cr, or OPM <15%, or FY27 guidance <8% growth, or Staffordshire/Innovaccer deals lack revenue contribution timeline in earnings call.

win score
63

HSCL 15dQ8PARTLY_PRICED added 26 Oct 16:20 · valid to 2026-11-10 · since added

Catalyst · CAPACITY: ₹1,613 Cr capacity expansion (battery materials ramp); Q3 FY27 margin recovery & capex progress update (Jan 2027) (2027-01-25)

Specialty chemicals: Q2 FY27 sales ₹1,691 Cr (+58% YoY), PAT ₹231 Cr (+29% YoY). H1 FY27 revenue ₹3,123 Cr, PAT ₹460 Cr. FY28 guidance ₹1,100 Cr+ PAT reiterated 22-Oct. ₹1,613 Cr capacity expansion (battery materials, carbon). ROCE 22.1%, ROE 17.8%, 5Y profit CAGR 74%. Concern: OPM flat 19% despite 58% revenue growth; margin pressure from capex/execution drag.

Why now: H1 FY27 beat (₹3,123 Cr revenue, ₹460 Cr PAT) and FY28 guidance (₹1,100 Cr+ PAT) reiterated 22-Oct. Stock down 33.9% in 3m despite earnings beat; margin pressure and execution timing concerns created

Entry zone 505.0–525.0 · stop 475.0 · target 560.0–590.0 · now None

Wrong if: OPM compression continues below 18%; capex execution delays or ROI miss; battery materials ramp slower than guided; interest expense rises above ₹35 Cr/Q.

win score
63

MPHASIS 15dQ7PARTLY_PRICED added 21 Oct 16:20 · valid to 2026-11-05 · since added

Catalyst · RESULTS: Q3 FY27 results + buyback decision (31-Jan-2027); Social Security Scotland deal revenue ramp in H2 FY27; ESOP grant (10-Oct) signals retention focus. (2027-01-31)

Q2 FY27: sales ₹4,384 Cr (+17.5% YoY), NP ₹490 Cr (+10.7% YoY), OPM stable 18-19%. Social Security Scotland £35.4M deal (8-Oct) for benefits management. HDFC MF raised stake to 7.06% (13-Oct). ROCE 22%, ROE 18.5%. Improving trajectory after prior 15d exit at +8.9%.

Why now: Prior zone exit 13-Oct on thesis break (mid-cap earnings tailwind reversed). Current price ₹2,575 (+3% from ₹2,500). Reentry only on fresh earnings beat or buyback announcement. Watch for Q3 accretion

Entry zone 2480.0–2540.0 · stop 2380.0 · target 2720.0–2820.0 · now None

Wrong if: Revised tax demand ₹2,418 Cr (14-Oct) escalates to cash outflow >₹500 Cr in Q3, or promoter pledge called (100% pledged, 30.5% holding), or debtor days exceed 100 days.

win score
60

COFORGE 15dQ8PARTLY_PRICED added 26 Oct 16:20 · valid to 2026-11-10 · since added

Catalyst · RESULTS: Cigniti integration milestones & Q3 FY27 results (Jan 2027) with margin guidance update (2027-01-15)

IT services: Q2 FY27 sales ₹5,528 Cr (+49% YoY, +11.6% QoQ CC), Sep Q ₹6,171 Cr (+54% YoY). OPM stable 19-20%. Cigniti acquisition closed 21-Oct. 8 large deals signed Q2 (highest ever). Order book +30% YoY. ROCE 23.5%, ROE 21.4%, debt-free. FII holding fell 42.5%→24.8% (10mo), creating entry opportunity if organic growth accelerates.

Why now: Cigniti closed 21-Oct; deal momentum (8 large deals Q2) and FII re-entry signal if organic growth >15% CC in Q3. Stock near 52w high (₹2,021), but FII exodus creates dip-buy setup.

Entry zone 1860.0–1920.0 · stop 1780.0 · target 2000.0–2060.0 · now None

Wrong if: Tax rate normalization or organic growth <10% CC in Q3; depreciation spike from Cigniti amortization compresses EPS below ₹45 annualized.

win score
60

SKYGOLD 15dQ8FRESH added 21 Oct 16:20 · valid to 2026-11-05 · since added

Catalyst · RESULTS: Q2 FY27 (Oct-Dec 2026) results: Purvi Gems accretion and margin impact; Dubai office export ramp; studded jewellery revenue synergy realization. (2027-01-15)

Q1 FY27: sales ₹2,013 Cr (+78% YoY), NP ₹105 Cr (+139% YoY), OPM 8% (+100 bps QoQ). Purvi Gems acquisition (7-Oct, ₹9 Cr) for studded jewellery entry. ROCE 26.9%, ROE 28.9%. Stock +188% 1y, +154% 6m. Concerns: P/E 48.9, P/B 13.5x, zero dividend, promoter stake fell 21.8% over 3y (now 51.7%).

Why now: Purvi Gems acquisition 2 weeks old; integration and accretion evidence pending. Desk history (16-Oct) set 15d idea: entry 1020-1050, stop 980, target 1120-1180, size 8%. Current ₹1,056 near upper entr

Entry zone 1020.0–1050.0 · stop 980.0 · target 1120.0–1180.0 · now None

Wrong if: Purvi Gems fails to deliver margin or revenue synergy in Q2, or gold price volatility compresses OPM below 7%, or promoter stake falls below 50%, or valuation correction (P/E >50) triggers macro-driven selloff.

win score
58

SENCO 30dQ6FRESH added 30 Oct 16:20 · valid to 2026-11-29 · since added

Catalyst · RESULTS: Q3 FY27 results (Nov/Dec 2026) for OPM recovery and same-store sales trend; Melorra acquisition completion (Feb 2027) for integration synergy (2026-11-30)

Senco Gold: jewelry retail, ROCE 21.2%, ROE 25.6%. Q2 FY27 sales ₹3,056 Cr (+67.4% YoY), but OPM fell to 7% from 10% QoQ and 13% in Dec 2025. NP ₹101 Cr (-56% QoQ, -4% YoY). TTM sales ₹9,660 Cr (+43% YoY), TTM profit ₹571 Cr (+168% YoY). Melorra acquisition (68% stake, ₹68 Cr, completion Feb 2027) signals organized jewelry consolidation. Q3 outlook flagged as 'strong' (Oct 8 news). Stock down 27.6% in 3m from ₹430 high.

Why now: OPM compression in Jun 2026 (7%) vs Dec 2025 (13%) signals gold price headwinds. Entry 310-320 (current ₹294 is near support). Melorra synergy realization begins Feb 2027 (4 months out). Rewatch after

Entry zone 310.0–320.0 · stop 290.0 · target 360.0–380.0 · now None

Wrong if: OPM <7% in Q3, same-store sales growth <10%, or Melorra acquisition delayed beyond Feb 2027

win score
58

IGIL 15dQ8PARTLY_PRICED added 30 Oct 16:20 · valid to 2026-11-14 · since added

Catalyst · RESULTS: Q3 FY27 results (Jan 2027) to confirm WC normalization and margin sustenance >60%; any FY27 guidance on 25%+ sales CAGR and ROCE >65% would re-rate (2027-01-15)

International Gemological Institute: debt-free gem certification monopoly, ROCE 69%, ROE 56%, Q2 FY27 sales ₹398 Cr (+31% YoY), NP ₹186 Cr (+43% YoY). OPM 61% sustained. Four-quarter sales trajectory 320→369→371→398 Cr (consistent acceleration). Promoter 76.6%, FII/DII 14.3%. Valuation P/E 25.8x, P/B 10.2x stretched but quality warrants premium. Working capital days deteriorated -103→+113 (watch for FCF compression).

Why now: Stock at RS 99.6th percentile, +22.6% in 1m, but -5.4% from 52w high. Earnings call transcript (28 Oct) released; no new catalyst yet but consolidation near highs sets up next leg if Q3 confirms traje

Entry zone 385.0–395.0 · stop 370.0 · target 420.0–440.0 · now None

Wrong if: WC days >120 in Q3, OPM <58%, or any guidance miss on sales growth <20% YoY

win score
58

PNBHOUSING 30dQ5PARTLY_PRICED added 14 Oct 16:19 · valid to 2026-11-13 · since added

Catalyst · RESULTS: Q2 FY27 results (~30 Oct): confirm NIM expansion (5-8 bps per CEO 11 Oct), NPA trend, loan growth rate (2026-10-30)

Housing finance; Q1 FY27 revenue ₹2,263 Cr (+4.3% QoQ), PAT ₹557 Cr (+4.3% YoY). Financing margin 32%, Gross NPA 0.95% (down from 1.06% Jun 2025). AAA rating upgrades (CRISIL 7 Oct, ICRA 25 Sep). ROCE 9.4%, ROE 12.7%. Improving trajectory: credit quality, loan book expanding.

Why now: AAA upgrades (7 Oct) + CEO commentary (11 Oct) on NIM gain from RBI rate hike; Q2 results within 30d window; stock +42% in 1y but valuation P/E 13.5 fair

Entry zone 1180.0–1210.0 · stop 1140.0 · target 1280.0–1320.0 · now None

Wrong if: Q2 NIM compression or NPA uptick; loan growth <10% YoY; DII holding reversal (45.7% Jun 2026) on profit miss

win score
57

QUESS 15dQ8PARTLY_PRICED added 27 Oct 16:20 · valid to 2026-11-11 · since added

Catalyst · RESULTS: Board meeting 30-Oct to approve Q2 FY27 results and interim dividend; analyst call 2-Nov. Allsec acquisition (2026-10-30) may be announced. (2026-10-30)

Business services (staffing, IT hiring). Q1 FY27: sales ₹4,182 Cr (+7.5% QoQ, +14.5% YoY), NP ₹82 Cr (+18% QoQ, +60% YoY). OPM flat 2.0% but profit leverage strong. CEO signals IT hiring acceleration in AI/ML/cybersecurity. ROCE 24%, ROE 21.3%.

Why now: Desk history shows 15d zone idea (entry 315-325, stop 300, target 345-360, conf 0.52) logged 26-Oct. Current price 323.35 near entry band. Margin recovery and dividend upside are catalysts; execution

Entry zone 315.0–325.0 · stop 300.0 · target 345.0–360.0 · now None

Wrong if: Q2 OPM <2.0%, sales <₹4,100 Cr, or dividend payout <₹2/share. Allsec acquisition terms unfavorable (>10x EBITDA). FII holding falls below 9%.

win score
55

ULTRACEMCO 15dQ5PARTLY_PRICED added 22 Oct 16:19 · valid to 2026-11-06 · since added

Catalyst · POLICY: Post-festive cement price hikes (Nov–Dec realization); Q3 FY27 results (Jan 2027) to confirm Rs 1,400 EBITDA/tonne progress and margin sustenance. (2026-12-15)

Q2 FY27: sales Rs 23,295 Cr (+19% YoY), profit Rs 1,501 Cr (+21% YoY). OPM 16% (down from 16% prior Q but up from 12% Sep 2025). TTM profit Rs 8,835 Cr vs Rs 8,188 Cr (Mar 2026). ROCE 12.7%, ROE 11.1%. Promoter 58.5% (down -0.85% last Q), DII 20.9%, FII 12.2% (down from 18.2% Dec 2023). Management flagged Rs 1,400 EBITDA/tonne target by FY27 end and post-festive price hikes (21 Oct call). Brokerages: Jefferies +34% upside, Elara Buy Rs 13,006 target.

Why now: Q2 profit growth +21% YoY and volume momentum (sales +19%) are real. Management guidance on Rs 1,400 EBITDA/tonne and post-festive price hikes (flagged 21 Oct call) are 15–30d catalysts. Brokerages (J

Entry zone 10800.0–11000.0 · stop 10400.0 · target 11800.0–12400.0 · now 11045.0

Wrong if: Cement demand slowdown if infrastructure/real estate cycle cools; input cost inflation (fuel, energy) eroding margins faster than pricing can offset; promoter dilution accelerating; FII outflow signals foreign capital loss of confidence.

win score
55

BHEL 30dQ6PARTLY_PRICED added 19 Oct 16:19 · valid to 2026-11-18 · since added

Catalyst · APPROVAL: Merger effective 01-Nov-2026; ₹500 Cr capex expansion; order inflows tracking ₹80K Cr by FY29 (2026-11-01)

Q2 FY27: sales ₹9,300 Cr (+24% YoY), OPM 11% (vs 8% YoY), NP ₹821 Cr (+120%). Order book ₹2.57L Cr. Merger effective 01-Nov-2026, ₹500 Cr HEEP-Haridwar capex approved. TTM sales +33%, PAT +439%. ROCE 9.14%, ROE 6.23% still subpar but trajectory improving. Quality 4/10.

Why now: Q2 beat priced in with -5% sell-off. Merger (01-Nov) and capex approval are 13-day catalysts. Stock near VWAP ₹427; wait for stabilization or fresh order announcement before 30d entry.

Entry zone 415.0–430.0 · stop 395.0 · target 460.0–480.0 · now None

Wrong if: Order inflows miss ₹15K Cr/quarter; ROCE/ROE fail to improve; valuation P/E 51.7 compresses if growth stalls.

win score
52

TCS 15dQ7PARTLY_PRICED added 23 Oct 16:19 · valid to 2026-11-07 · since added

Catalyst · OTHER: USA non-deal roadshow 22-27 Oct; FY27 guidance signals from earnings call (14-Oct transcript filed); Industrial Intelligence Foundry adoption ramp next 2-3 qtrs (2026-10-27)

Q2 FY27 (Sep 2026): sales ₹73,188 Cr (+11.4% YoY), profit ₹13,934 Cr (+12.6% YoY). OPM 26% stable. BBY Services acquisition closed 15-Oct, Industrial Intelligence Foundry launched 15-Oct, Porsche 5-yr deal, ₹122.6 Cr Odisha order. ROCE 63%, ROE 52%, debt-free. Growth steady 10-12% but not accelerating. FII outflow (12.7% → 9.01% in 18m) signals caution. Valuation P/E 16.8 vs historical 20-22 offers margin of safety.

Why now: Roadshow this week may clarify FY27 deal pipeline, margin trajectory, AI revenue ramp. Stock +7.7% 1w, +20.2% 1m but still -17.7% 1y; re-rating if guidance raises growth forecast.

Entry zone 2480.0–2540.0 · stop 2380.0 · target 2650.0–2720.0 · now None

Wrong if: If roadshow commentary signals margin compression or deal pipeline slowdown below 10% growth, or if FII selling accelerates post-roadshow.

win score
50

APARINDS 15dQ8ALREADY_PRICED added 30 Oct 16:20 · valid to 2026-11-14 · since added

Catalyst · RESULTS: Q3 FY27 (Jan 2027): capex deployment update on ₹1,500 Cr FY27 plan; margin sustainability test. FY27 full-year results (May 2027): confirm if OPM >10% sustainable. (2027-01-15)

Apar Industries: conductor/cable/transformer oil, ROCE 31.8%, ROE 20.3%. Q2 FY27 sales ₹6,931 Cr (+21.3% YoY), NP ₹447 Cr (+78% YoY). OPM 10% (+2pts QoQ). Valuation stretched: P/E 46.9, P/B 7.62. Promoter holding fell 2.34% Jun→Sep 2026 (57.77%→55.42%), signalling dilution. High interest cost (₹504 Cr TTM, +13% YoY). Q2 beat is real but valuation leaves no margin of safety.

Why now: Q2 beat (NP +78% YoY, sales +21% YoY) is real, but valuation (P/E 46.9, P/B 7.62) leaves no margin of safety. Promoter selling (-2.34% Jun→Sep) is yellow flag. Watch for capex execution and margin sus

Entry zone 15000.0–15200.0 · stop 14500.0 · target 16200.0–16800.0 · now None

Wrong if: OPM <9% in Q3, promoter dilution accelerates >1% per quarter, or capex ROI <15% on ₹1,500 Cr plan

win score
50

HCLTECH 15dQ7PARTLY_PRICED added 26 Oct 16:20 · valid to 2026-11-10 · since added

Catalyst · RESULTS: Q3 FY27 results (Jan 2027) confirm deal conversion & margin trajectory; Rapidus semiconductor partnership (26-Oct) revenue ramp (2027-01-15)

IT services: Q2 FY27 sales ₹35,620 Cr (+12% YoY, +2.3% QoQ), PAT ₹5,132 Cr (+21% YoY, +10.9% QoQ). Deal bookings $3.3B (+27% YoY). OPM stable 21%. Interim dividend ₹12/share declared 12-Oct. ROCE 30.4%, ROE 23.8%, debt-free, 3.85% dividend yield. Analyst upgrades (CLSA, JPMorgan, Jefferies) post-results. Concern: organic dollar revenue growth 2.3% QoQ below consensus 2.7%.

Why now: Q2 results (12-Oct) beat consensus; deal pipeline strong ($3.3B bookings). Stock broke above SMA50/200, near 20d high (₹1,780). Interim dividend ₹12/share declared. Analyst upgrades post-results. 15d

Entry zone 1390.0–1420.0 · stop 1330.0 · target 1480.0–1520.0 · now None

Wrong if: Organic dollar revenue growth decelerates below 2% QoQ in Q3; OPM compresses below 20%; FII holding falls below 14%; macro IT services demand cyclicality worsens.

win score
48

AETHER 15dQ6PARTLY_PRICED added 27 Oct 16:20 · valid to 2026-11-11 · since added

Catalyst · RESULTS: Board meeting 30-Oct (3 days) to approve Q2 FY27 results; earnings call same day. Analyst consensus lifted fair value to ₹1,541 (vs current ₹1,537). (2026-10-30)

Specialty chemicals (sole-source supplier for 4MEP, MMBC, T2E, OTBN). Q1 FY27: sales ₹327 Cr (+27% YoY), OPM 31% (stable), NP ₹63 Cr (+34% YoY). TTM sales ₹1,231 Cr (+34%), profit ₹235 Cr (+30%). ROCE 11.9%, ROE 9.66% (below 15% hurdle). Debt-free.

Why now: Q2 guidance will confirm 25%+ growth and margin hold >30%. Promoter stake fell 81.8% (Dec 2023) → 74.9% (Mar 2025), now 74.92% (Sep 2026)—dilution ongoing but controlled. If Q2 guidance confirms traje

Entry zone 1520.0–1560.0 · stop 1430.0 · target 1620.0–1700.0 · now None

Wrong if: Q2 sales <₹310 Cr, OPM <28%, or capex guidance >₹150 Cr (ROI uncertainty). Customer concentration risk disclosed (>30% revenue from single OEM). CGST notice reappears.

win score
42

WIPRO 15dQ6ALREADY_PRICED added 30 Oct 16:20 · valid to 2026-11-14 · since added

Catalyst · RESULTS: Q3 FY27 results (late Jan 2027) must show deal bookings recovery and margin re-expansion; FLARRE.AI acquisition close (Oct 31, 2026) (2027-01-25)

Wipro: IT services, ROCE 17.8%, ROE 15.5%. Q2 FY27 sales ₹24,753 Cr (+9.1% YoY, +1.1% QoQ), NP ₹3,200 Cr (-1.4% YoY, -4.6% QoQ). OPM 20% flat. Q3 guidance -1.5% to +0.5% signals deceleration. Deal bookings weakest in 15 quarters. FLARRE.AI acquisition (20% stake, Oct 31 close) adds AI/ML capability. Dividend yield 5.6% attractive. Desk logged 15d idea Oct 29: entry 186-193, stop 178, target 205-215 (conf 0.52). Current 198.3 within entry band but Oct 23 log warns 'DO NOT TOUCH'.

Why now: Stock +26.5% in 1m, RS 91.5th percentile, but deal pipeline broken and Q3 guidance weak. FLARRE.AI close (Oct 31) is near-term signal of AI pivot. Risk/reward unclear until deal pipeline stabilizes.

Entry zone 186.0–193.0 · stop 178.0 · target 205.0–215.0 · now None

Wrong if: Q3 guidance miss (revenue <-1.5%), deal bookings <$3B, or headcount reduction >8% YoY

added	ticker	hz	score	catalyst	at	now	outcome
23 Oct 16:19	INFY	7d	57	Q2 FY27 results, FY27 revenue guidance, AI services revenue % disclosure (RELEAS	None	None	WAITING
19 Oct 16:19	ELECON	15d	67	Interim dividend ex-date 21 Oct; Q3 FY27 order book growth and export revenue %	None	None	FILLED
16 Oct 16:19	HBLENGINE	15d	63	CARE upgrade + Tonbo IPO stake realization + Q2 FY27 results (Nov est.)	None	None	FILLED
16 Oct 16:19	TECHM	7d	62	IT sector momentum + Q2 beat + margin expansion confirmation	None	None	FILLED
16 Oct 16:19	ORIENTELEC	15d	68	Q2 earnings beat + CARE upgrade + analyst target ₹240 (+19% upside)	None	None	FILLED
15 Oct 16:19	GALLANTT	15d	42	Earnings call (14 Oct, already held): management guidance on volume, pricing, ca	628.15	None	WAITING
15 Oct 16:19	TARIL	15d	73	FY27 guidance raise and capacity expansion announcement expected within 2-3 week	333.45	None	FILLED
14 Oct 16:19	BLACKBUCK	15d	52	Q2 FY27 earnings (Nov 2026): test if Loads separation improves consolidated marg	598.65	None	WAITING
14 Oct 16:19	REDINGTON	15d	55	Q2 FY27 results (Nov 2026): test OPM expansion and OPSWAT/Siemens deal contribut	401.6	None	WAITING
14 Oct 16:19	TARIL	15d	68	Order book conversion: ₹7,237 Cr backlog drives FY27 revenue to ₹3,200-3,400 Cr;	349.5	None	FILLED
13 Oct 16:19	TECHM	7d	63	Q2 FY27 results + bonus/interim dividend announcement 15 Oct	1543.5	None	FILLED
13 Oct 16:19	HCLTECH	7d	67	Dividend ex-date 16 Oct; Q3 guidance clarity on AI monetization and deal convers	1326.0	None	FILLED
13 Oct 12:57	FINEORG	15d	52	Q2 FY27 results (mid-Oct); SEZ unit commissioning (FY27–28); West Asia/China sup	5399.0	None	WAITING
13 Oct 12:57	NAVINFLUOR	15d	67	Q2 FY27 results (30 Oct board meeting); Dahej capacity ramp-up; interim dividend	8359.0	None	FILLED
13 Oct 12:57	HEXT	15d	73	Anthropic partnership deal ramp-up; Q3 FY26 earnings (Jan'27) to show AI en	562.45	None	FILLED
08 Oct 12:17	EMMVEE	30d	None	Q2 FY27 (Sep 2026) results: confirm sales recovery and working capital normaliza	None	None	FILLED
08 Oct 12:17	EMIL	15d	None	Q2 FY27 results (Oct-Dec 2026): confirm >12% OPM, >18% YoY sales growth; s	None	None	FILLED
08 Oct 12:17	TRENT	15d	None	29-Oct board approval & formal Q2/H1 FY27 results; Zudio expansion pace &	None	None	FILLED

Ideas — 7 to 30 day suggestions, ranked by win score (01 Nov 2026 22:22 IST, research-led; only the top 3 are traded by the zone book)

Earlier suggestions and how they went